Program Image Neurobiology: Psychopharmacology and Pathophysiology

Neurobiology: Psychopharmacology and Pathophysiology

Master

University of Amsterdam mapmarker icon Amsterdam Research university
Institution Logo University of Amsterdam

The aim of the track is to give insight into: the neurobiological substrate of human brain disorders; current pharmaca and their mechanisms of action; and research to develop and test new drugs.

The main aim of this track is to provide you with detailed and up-to-date information about:

1) the neurobiological mechanisms thought to underlie some of the main human brain disorders, e.g. Alzheimer's/Parkinson's disease, depression, anxiety, eating disorders, addiction, epilepsy and MS. 

2) the current animal models available to study these diseases and/or test effects of (novel) pharmaca.

3) the development, selection and testing of drugs to treat brain diseases (validity, efficacy, safety). This is done with experts from the pharma industry. As risk factors for later psychopathology, focus is also on the early life period and on stress. Other key topics are nutrition, plasticity and stem cells.

Language

English

Title

-

Duration

2 years

ECTS credits

Accreditation

Information not available

Numerus Fixus

Tuition fee 2024/2025

€ 2,530

€ 17,380

€ 15,800


Admission

Application requirements

Information not available

Check when you can start and what you have to pay!

Tuition fees  
€ 2,530
€ 17,380
€ 15,800
Start date App. deadline EU/EEA App. deadline Non-EU/EEA
1 Sep '24 1 May '24 1 Feb '24

Contact

University of Amsterdam

Main address
Gebouw E, Roetersstraat 11
1018 WB Amsterdam
020-525 1401

Ready to apply?

Visit course website chevron icon
University of Amsterdam institution image
University of Amsterdam institution image